Policy & Medicine

ICER Report Takes Aim at Seven Prescription Drug Price Increases

Thomas Sullivan Jan 14, 2022 0

In December 2021, the Institute for Clinical and Economic Review (ICER) released a new report on Unsupported Price Increases (UPI) of prescription drugs in the United States. In the report, ICER takes issue with seven particular drug price increases in 2020. Those seven “unsupported price increases” cost the United States health system an…

Policy and Medicine Compliance Update December 2021 —…

Thomas Sullivan Dec 18, 2021 0

November Issue of Policy and Medicine Compliance Update…

Thomas Sullivan Nov 13, 2021 0

ICER Report Takes Aim at Seven Prescription Drug Price Increases

CMMI Pulls Seriously Ill Component of Primary Care First Model

Recently, the Center for Medicare and Medicaid Innovation (CMMI) withdrew the seriously ill population component of the Primary Care First model, based on concerns over whether it would get enough…

Centene Corporation Reaches Another State PBM Settlement in…

Centene Corporation recently agreed to settle another pharmacy benefit management case, this time in Kansas. The $27.6 million settlement was announced by Kansas Attorney General Derek Schmidt, who…

RWD May Not Be Ready for Prime-Time Postapproval Confirmatory…

In November 2021, Joshua D. Wallach, PhD, MS and six other researchers, published a research letter in JAMA Network Open discussing the feasibility of using real-world data (RWD) to emulate…

HHS OIG Releases Data Brief on Trends with Rapid Growth of…

In December 2021, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) released a data brief that provided insights into trends and areas of possible concern…

HHS OIG Report Finds Many Medicare Beneficiaries Are Not…

In mid-December 2021, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) released a data brief that found many Medicare beneficiaries are not receiving…

House Oversight Publishes Competing Views of Drug Pricing…

Highlighting the partisan nature of Congress these days, the House Oversight and Reform Committee and the Republicans on the Committee each recently published two separate reports that present…

Pharma Exec Charged with Hiding Company Money, Using it For…

In early December 2021, John Klein, a former majority shareholder and executive of an unnamed pharmaceutical company, was charged with embezzling millions of dollars from his company to pay for…

AAFP Eliminates In-Person CME Requirement

In late 2021, the American Academy of Family Physicians (AAFP) eliminated the requirement for active members to earn 25 credits of CME through live, in-person activities. AAFP notes that this change…

Bipartisan Representatives Oppose MCIT Repeal

It’s hard to find topics of bipartisan agreement these days in Washington, D.C. However, more than 60 House Representatives from both political parties recently signed a letter to Centers for Medicare…

False Claims Amendments Act of 2021 Continues to Wind Through…

Earlier this year, Senator Chuck Grassley and a bipartisan group of senators introduced the False Claims Amendment Act of 2021, which attempts to revise and “beef up” the False Claims Act to help the…

FDA Issues Two Draft Guidance Documents on Real-World Data

At the end of 2021, the United States Food and Drug Administration (FDA) issued two draft guidance documents that outline the agency’s recommendations for using real-world data. Assessing…